Significantly more patients achieved their secondary passive goal with onabotulinumtoxinA + standard of care ( @ % ) vs. placebo + standard of care ( @ % ) ( odds ratio , @ ; @ % confidence interval , @-@ @ ) as well as higher Goal Attainment Scaling levels for upper limb and ankle flexor subgroups .